Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/20/2025

Treatment of Facial Eczema

First-Line Treatment Approach

  • The British Medical Journal recommends applying low-potency topical corticosteroids, such as 1% hydrocortisone, twice daily as first-line treatment for facial eczema, using the least potent preparation that controls symptoms, with special caution given the thin facial skin and high risk of atrophy 1, 2, 3
  • Start with low-to-moderate potency topical corticosteroids applied twice daily maximum to affected facial areas, as recommended by the British Medical Journal 1, 2, 3
  • Use 1% hydrocortisone or equivalent mild-potency preparations for facial eczema, as this provides adequate control without causing systemic side effects when used appropriately, according to the British Medical Journal 1
  • Implement "steroid holidays"—stop corticosteroids for short periods once symptoms improve to minimize pituitary-adrenal suppression and local side effects, as suggested by the British Medical Journal 1, 2

Essential Emollient Therapy

  • Apply emollients liberally and regularly to the entire face, even when eczema appears controlled, as this is the cornerstone of maintenance therapy, recommended by the British Medical Journal 1, 2
  • Apply emollients immediately after bathing to provide a surface lipid film that prevents evaporative water loss from the epidermis, as advised by the British Medical Journal 1, 2
  • Use dispersible cream as a soap substitute instead of regular soap, which strips natural lipids and worsens the already compromised skin barrier, according to the British Medical Journal 1, 4

Managing Secondary Infections

  • Watch for signs of bacterial superinfection: increased crusting, weeping, or pustules on facial skin, as recommended by the British Medical Journal 4, 5, 2
  • Prescribe oral flucloxacillin as first-line antibiotic for Staphylococcus aureus, the most common pathogen in infected eczema, according to the British Medical Journal 1, 2
  • Continue topical corticosteroids during bacterial infection when appropriate systemic antibiotics are given concurrently—infection is not a contraindication to topical steroid use, as suggested by the British Medical Journal 2, 6

Managing Pruritus

  • Sedating antihistamines, such as hydroxyzine or diphenhydramine, may help with nighttime facial itching through their sedative properties, not through direct anti-pruritic effects—reserve for nighttime use during severe flares only, as recommended by the British Medical Journal 1, 2, 4

Critical Pitfalls to Avoid

  • Never delay or withhold topical corticosteroids when facial infection is present—they remain the primary treatment when appropriate systemic antibiotics are given concurrently, as advised by the British Medical Journal 2, 6
  • Do not undertreat facial eczema due to steroid phobia—explain to patients that appropriate short-term use of low-potency steroids is safer than chronic undertreated inflammation, according to the British Medical Journal 1, 2
  • Avoid potent or very potent corticosteroids on facial skin due to extremely high risk of atrophy, telangiectasia, and perioral dermatitis, as recommended by the British Medical Journal 1, 3

When to Refer to Dermatology

  • Failure to respond to low-potency topical corticosteroids after 4 weeks of appropriate use, as suggested by the British Medical Journal 2, 3
  • Suspected eczema herpeticum (refer emergently), according to the British Medical Journal 2, 3